The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...
Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying ...
US-listed shares of Novo jumped 8 per cent and Lilly fell 1 per cent in extended trading after the approval announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback